IP Library Granted Patent US 12,295,916
Granted Patent B2
US 12,295,916 · App. 16/873,552 · Granted May 13, 2025

Process for making aqueous therapeutic particle having stable exterior water clustering with nanosized thickness

Inventors: Karl P. Dresdner, Jr. (Haddonfield, NJ); Michael Raymond Cary (Lexington, SC); Chase Hudson (Provo, UT); Nathan A. Beckham (Provo, UT)
A61J3/07A23L2/52A61K9/0095A61K9/5115A61K9/5192A61K31/05C02F9/00A23V2002/00C02F1/001C02F1/32C02F1/441C02F1/4691C02F2103/04
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,295,916
App. No.
16/873,552
Granted
May 13, 2025
Kind
B2
Abstract

The invention relates to processes for making pharmaceutical aqueous therapeutic particles (AQTP) having stable exterior water clustering with nanosized thickness less than 300 nanometers, wherein the AQTP has an improved bioavailability when administered to a mammal compared to conventional pharmaceutical drug particles administered to the mammal. The invention relates to an improved process apparatus which is computer controlled, capable of continuous operation with high efficiency so as to make a more consistently acceptable AQTP compared to an previous prototype process apparatus of the Inventors. The invention provides compositions comprising of AQTP which comprise a substance selected from the group consisting of a cannabinoid such as CBD, a cell membrane pore-forming peptide such as PNC-27, a psychoactive drug, a pharmaceutical, a nutraceuticals, a mineral, an anion, a cation, a protein, a peptide, an amino acid, a polymer, a vitamins, an antioxidants, a fertilizer, a chemical, a medical use product, a medical kit use product, a personal consumer use product, a manufacturing use product, a energy use product such as a battery, and any combination thereof.

Claims (24)

1. A process for making a composition comprising nanosized water clusters encapsulating therapeutic particles of a non-H 2 O substance in a purified water, the process comprising the steps of:

mixing an ingredient comprising the therapeutic particles of the non-H 2 O substance with the purified water to make a mixture comprising water clusters encapsulating the therapeutic particles of the non-H 2 O substance in the purified water;

flowing a process stream comprising the mixture through a transfer pipe and a nozzle having a single jet opening into and through a hollow cylinder cavity in a hollow cylinder to make the composition comprising the nanosized water clusters encapsulating the therapeutic particles of the non-H 2 O substance in the purified water in the process stream,

wherein the nozzle having the single jet opening is situated at a proximal end inside the hollow cylinder cavity and comprises:

(i) a nozzle proximal side with one nozzle input opening connected to the transfer pipe;

(ii) the single jet opening with one jet bore hole through the nozzle connected to the one nozzle input opening; and

(iii) a nozzle distal side where the one jet bore hole is directed to expel the process stream from outer surface of the nozzle at an angle into the hollow cylinder cavity towards an inner surface of the hollow cylinder, and

wherein the process stream contacts the inner surface of the hollow cylinder wall and has a spiral flow pattern through the hollow cylinder cavity directed towards distal end of the hollow cylinder; and

removing the composition comprising the nanosized water clusters encapsulating the therapeutic particles of the non-H 2 O substance in the purified water from the hollow cylinder cavity,

wherein the composition comprising the nanosized water clusters encapsulating the therapeutic particles of the non-H 2 O substance in the purified water has an increased bioavailability compared to the bioavailability of the mixture comprising the water clusters encapsulating the therapeutic particles of the non-H 2 O substance in the purified water.

2. The process according to claim 1 , wherein the purified water is purified by a water purification treatment comprising a 0.1 micron to 20 microns filter exclusion size filtration treatment, a distillation treatment, a carbon filtration treatment, a reverse osmosis treatment, an electro-deionization treatment, a molecular sieve chromatography treatment, an ultraviolet light irradiation treatment, a sand filtration treatment, or any combination thereof.

3. The process according to claim 1 , wherein the process stream flowing through the transfer pipe is at a flow rate in gallons per minute selected from the group consisting of 0.5 to about 5, about 5 to 5.5, about 5.5 to 6, about 6 to 6.5, about 6.5 to 7, about 7 to 7.5, about 7.5 to 8, about 8 to 8.5, about 8.5 to 9, about 9 to 9.5, about 9.5 to 10, about 10 to 10.5, about 10.5 to 11, about 11 to 11.5, about 11.5 to 12, about 12 to 12.5, about 12.5 to 13, about 13 to 13.5, about 13.5 to 14, about 14 to 14.5, about 14.5 to 15, about 15 to 15.5, about 15.5 to 16, about 16 to 17, about 17 to 17.5, about 17.5 to 18, about 18 to 18.5, about 18.5 to 19, about 19 to 19.5, about 19.5 to 20, about 20 to 20.5, about 20.5 to 21, about 21 to 21.5, about 21.5 to 22, about 22 to 22.5, about 22.5 to 23, about 23 to 23.5, about 23.5 to 24, about 24 to 24.5, about 24.5 to 25, about 25 to 30, about 30 to 35, and about 35 to 40, about 40 to 45, about 45 to 50, about 50 to 60, about 60 to 70, about 70 to 80, about 80 to 90, about 90 to 100, about 100 to 150, about 150 to 300, and any combination thereof.

4. The process according to claim 1 , wherein the process stream flowing through the transfer pipe is at a pressure in pounds per square inch selected from the group consisting of 10-20 psi, 20-30 psi, 30-40 psi, 40-50 psi, 50-60 psi, and 60-70 psi.

5. The process according to claim 1 , wherein the hollow cylinder cavity has an inner width in inches selected from the group consisting of about 1 to 2 inches, about 2 to 3 inches, about 3 to 4 inches, about 4 to 5 inches, about 5 to 6 inches, about 6 to 7 inches, about 7 to 8 inches, about 8 to 9 inches, about 9 to 10 inches, about 10 to 11 inches, about 11 to 12 inches, about 12 to 13 inches, about 13 to 14 inches, about 14 to 15 inches, about 15 to 16 inches, about 16 to 17 inches, about 17 to 18 inches, about 18 to 19 inches, about 19 to 20 inches, and any combination thereof, and

wherein the hollow cylinder cavity has an inner length in inches selected from the group consisting of about 2 to 4 inches, about 4 to 6 inches, about 6 to 8 inches, about 8 to 10 inches, about 10 to 12 inches, about 12 to 14 inches, about 14 to 16 inches, about 16 to 18 inches, about 18 to 20 inches, about 20 to 22 inches, about 22 to 24 inches, about 24 to 26 inches, about 26 to 28 inches, about 28 to 30 inches, about 32 to 34 inches, about 34 to 36 inches, about 36 to 38 inches, about 38 to 40 inches, about 40 to 42 inches, about 42 to 44 inches, about 44 to 46 inches, about 46 to 48 inches, about 48 to 50, about 50 to 52, about 52 to 54, about 54 to 56, about 56 to 58, about 58 to 60, about 60 to 62, about 62 to 64, about 64 to 66, about 66 to 68, about 68 to 70, about 70 to 72, about 72 to 74, about 74 to 76, about 76 to 78, about 78 to 80, and any combination thereof.

6. The process according to claim 1 , wherein the process stream flowing through the transfer pipe is at a flow rate in gallons per minute which is a multiple of the hollow cylinder cavity volume in gallons, the multiple selected from the group consisting of about 1 to 2, about 2 to 3, about 3 to 4, about 4 to 5, about 5 to 6, about 6 to 7, about 7 to 8, about 8 to 9, about 9 to 10, about 10 to 11, about 11 to 12, about 12 to 13, about 13 to 14, about 14 to 15, about 15 to 16, about 16 to 17, about 17 to 18, about 18 to 19, about 19 to 20, about 20 to 21, about 21 to 22, about 22 to 23, about 23 to 24, about 24 to 25, about 25 to 26, about 26 to 27, about 27 to 28, about 28 to 29, and about 29 to 30.

7. The process according to claim 1 , wherein the nanosized water clusters encapsulating the therapeutic particles of the non-H 2 O substance in the purified water have sizes based on a DLS instrument measurement between about 1 nanometer to about 400 nanometers.

8. The process according to claim 1 , wherein the nanosized water clusters encapsulating the therapeutic particles of the non-H 2 O substance in the purified water have sizes based on a DLS instrument measurement selected from the group consisting of between about 2 nanometers to about 10 nanometers, between about 10 nanometers to about 30 nanometers, between about 30 nanometers to about 60 nanometers, between about 60 nanometers to about 120 nanometers, between about 120 nanometers to about 250 nanometers, between about 250 nanometers to about 500 nanometers, and any combination thereof.

9. The process according to claim 1 , further comprising a pump for controlling a flow rate of the process stream.

10. The process according to claim 1 , wherein the angle into the hollow cylinder cavity is selected from the group consisting of 0, 2, 4, 6, 8, 10, 12, 14, 16, 18, 20, 22, 24, 26, 28, 30, 32, 34, 36, 38, 40, 42, 44, 46, 48, 50, 52, 54, 56, 58, 60, 62, 64, 66, 68, 70, 72, 74, 76, 78, 80, 82, 84, 86, 88, and 90 degrees.

11. The process according to claim 1 , wherein the angle into the hollow cylinder cavity is about 45 degrees.

12. The process according to claim 1 , wherein the non-H 2 O substance comprises an organic liquid.

13. The process according to claim 1 , wherein the non-H 2 O substance comprises a fulvic humic liquid.

14. The process according to claim 1 , wherein the non-H 2 O substance comprises a potassium ion, a calcium ion, a magnesium ion, a copper ion, an iron ion, a manganese ion, a molybdenum ion, a zinc ion, a cobalt ion, a vanadium ion, a phosphate ion, a hydrogen phosphate ion, a dihydrogen phosphate ion, a nitrate ion, a nitrite ion, an ammonium ion, an amide ion, a sulfate ion, a sulfite ion, a borate ion, or a silicate ion.

Continuity (4)
Provisional Application 62921280 · Jun 8, 2019
Provisional Application 62920747 · May 13, 2019
Provisional Application 62920450 · Apr 30, 2019
Related Publication 20200345585A1 · Nov 5, 2020
References Cited (73)
US 4592909A · Winer et al. · 1986 [cited by applicant]
US 4876014A · Malson · 1989 [cited by applicant]
US 5435913A · Ashbrook · 1995 [cited by applicant]
US 6521248B1 · Holloway et al. · 2003 [cited by applicant]
US 7198254B2 · Holloway et al. · 2007 [cited by applicant]
US 7531515B2 · Pincus · 2009 [cited by applicant]
US 7745405B2 · Pincus · 2010 [cited by applicant]
US 7832920B2 · Wood et al. · 2010 [cited by applicant]
US 8193251B2 · Lo et al. · 2012 [cited by applicant]
US 8623212B2 · Irvin, Sr. · 2014 [cited by examiner]
US 9334200B2 · Kaiser · 2016 [cited by applicant]
US 9474991B2 · Irvin, Sr. et al. · 2016 [cited by applicant]
US 10508061B2 · Bunderson · 2019 [cited by applicant]
US 11198654B2 · Bunderson · 2021 [cited by applicant]
US 11344572B2 · Bishop · 2022 [cited by examiner]
US 11779645B2 · Bishop · 2023 [cited by examiner]
US 20050031657A1 · Gilson · 2005 [cited by applicant]
US 20060146644A1 · Holloway et al. · 2006 [cited by applicant]
US 20070186367A1 · Field · 2007 [cited by applicant]
US 20090017167A1 · Krumhar et al. · 2009 [cited by applicant]
US 20110218251A1 · Lo et al. · 2011 [cited by applicant]
US 20120039951A1 · Watson · 2012 [cited by applicant]
US 20170233303A1 · Bunderson · 2017 [cited by applicant]
US 20170290854A1 · Matlick · 2017 [cited by applicant]
US 20190358169A1 · Bishop · 2019 [cited by examiner]
US 20200121715A1 · Bishop · 2020 [cited by examiner]
US 20200223765A1 · Bunderson · 2020 [cited by applicant]
US 20200345585A1 · Dresdner, Jr. et al. · 2020 [cited by applicant]
US 20210353667A1 · Bishop · 2021 [cited by examiner]
WO WO2018179495A1 · 2018 [cited by applicant]
The Declaration of Michael Raymond Cary Regarding Public Use and Public Availability of Inventions Claimed in U.S. Appl. No. 16/350,259, Oct. 2020. [cited by examiner]
Keutish, Frank N., Saykally, Richard J. Water clusters: untangling the mysteries of the liquid, one molecule at a time, PNAS Sep. 1, 2001, pp. 10533-10540, vol. 98(19). [cited by applicant]
Plumridge, I.H., Waigh, H.D. Water structure theory and some implicaitons for drug design. JPP, 2002, pp. 1155-1179, vol. 54. [cited by applicant]
Stoyanov, Evgenii S. et al., The structure of the hydrogen ion (Haq+) in water. J. Am. Chem. Soc. , Feb. 10, 2010, pp. 1484-14, vol. 132(5). [cited by applicant]
Mechoulam, R.Hanus, L. Cannabidiol: an overview of some chemical and pharmacological aspects. Part 1: chemical aspects. Chemistry and Physics of Lipids, 2002,vol. 121,pp. 35-43. [cited by applicant]
Stukelj, Roman, et al. Synthesis of Stable Cannabidiol (CBD) Nanoparticles in Suspension. Materials & Technology 53 (2019) 4, 543-549. [cited by applicant]
Declaration of Michael Raymond Cary regarding Public Use and Public Availability of Inventions claimed in U.S. Appl. No. 16/350,259, signed Oct. 15, 2020, 33 pages. [cited by applicant]
Declaration of Michael Raymond Cary regarding Public Use and Public Availability of Inventions claimed in U.S. Appl. No. 16/421,163, signed Oct. 15, 2020, 33 pages. [cited by applicant]
U.S. Appl. No. 62/675,248, filed May 23, 2018; titled “Methods for Making, Compositions, and Uses of Nano-Sized Particles for Improved Biological Transport”. [cited by applicant]
Mike Cary 2013 OSML Farm Data Sheet Form 100 for Contracts 2 pages. [cited by applicant]
Mike Cary On-Site-Mobile-Laboratories Presentation—fertilizer Humic Acid nanoparticulation from 5 micron down to 6 nanometer particle based on Malvern test (24 pages). [cited by applicant]
Shirreffs et al. 2011 Fluid and Electrolyte needs for training, competition and recovery. Journal of Sports Sciences pp. S39-S46, vol. 29(S1). [cited by applicant]
Smith, Jared, D et al. 2005 Unified description of temperature-dependent hydrogen bond arrangements in liquid water. PNAS vol. 102 (40) pp. 14171-14174. [cited by applicant]
Aquaporin, 2018, from Wikipedia the free encyclopedia, 12 pages. [cited by applicant]
Dehydration 2018, from Wikipedia the free encyclopedia, 5 pages. [cited by applicant]
Larson, Rita, 2015, What is the real difference between Energy Drinks and Sports Drinks? Elite Sports Clubs, WordPress. [cited by applicant]
Chaplin, Martin 2018, Nanobubbles (ultrafine Bubbles) Water and Structure Science from http://www1.isbu.ac.uk/water/nanobubble.html, 13 pages. [cited by applicant]
Rozanska, S. & Rozanski, J, Extensional flow of Carboxymethylcellulose sodium salt measured on the opposed-nozzle device, Soft Materials:15(4):302-314, 2017. [cited by applicant]
Purified Water, Wikipedia, last updated by contributors on May 9, 2022. [cited by applicant]
“What is Potable Water?” NPL is a written document published at https://Bjus.com/Chemistry/Potable-Water, and retrieved on May 31, 2022. [cited by applicant]
U.S. Appl. No. 62/675,248, Bishop, Patrick, C. and 5 others. [cited by applicant]
Declaration of Michael R. Cary Regarding Public Use and Public Availability of Inventions Claimed in U.S. Appl. No. 16/350,259 mailed Oct. 15, 2020 (33 pages). [cited by applicant]
Declaration of Michael R. Cary Regarding Public Use and Public Availability of Inventions Claimed in U.S. Appl. No. 16/421,163 mailed Oct. 15, 2020 (33 pages). [cited by applicant]
Second Declaration of Michael R Cary Regarding Public Use and Public Availability of Inventions Claimed in U.S. Appl. No. 16/421,163 mailed Apr. 16, 2021 (36 pages). [cited by applicant]
Third Declaration of Michael R Cary Regarding Public Use and Public.Availability of Inventions Claimed in U.S. Appl. No. 16/421,163 mailed Jun. 7, 2021 (40 pages). [cited by applicant]
Bishop, Methods for Making Compositions and Uses of Nano-Sized Particles for Improved Biological Transport. U.S. Appl. No. 62/675,248, filed May 23, 18 (93pgs, 12 Figs). [cited by applicant]
Nestle Pure Life Bottled Water Quality Report, Nestle Waters North America, Inc., 2015 (14 pages). [cited by applicant]
Gravelle, S et al. “Optimizing water permeability through hourglass shape of aquaporins.” Proceedings National Academy Sciences vol. 10,No. 41,pp. 16367-16372, Oct. 8, 2013. [cited by applicant]
Mike Cary, 2013 On-Site Mobil Laboratories (OSML) 2 page Advertising Flyer with Warren Bell Testimonial 2 pages, Fertilizer particles reduced from 5 microns to 6 nanometer. [cited by applicant]
Mike Cary, 2013 Marketing Plan - Executive Summary—On-Site Mobil Laboratories (OSML's wet nano based technology for manipulating fertilizer to a nanoparticulate. 6 pages. [cited by applicant]
Mike Cary, 2013 OSML Marketing Plan Addendum No. 1 The process of wet nano manipulating and blending fertilizer was developed by Dr. James Kaiser 8 years ago. 2 pages. [cited by applicant]
Schieving, Aaron 2017. Understanding USP <1231> Water for Pharmaceutical Use from http://www.pharmatech.com/understanding-usp-water-pharmaceutical-use. 2 pgs. [cited by applicant]
Purified Water, 2018, from Wikipedia the free encyclopedia, 10 pages. [cited by applicant]
Tomaszewska, Emilia et al., 2013, Detection Limits of DLS and UV-Vis Spectroscopy in Characterization of Polydisperse Nanparticles Colloids. J Nanomaterials, ID 313081, 10pgs. [cited by applicant]
Trace Minerals, Ogden, Utah, Aug. 28, 2014, Kelly Jones, Certificate of Analysis, www.traceminerals.com, Trace Minerals Research, 2 pages. [cited by applicant]
Chaplin, Martin, 2007, Water's Hydrogen Bond Strengthpp. 1-20, Cornell University Library, https//arxiv.org<condmat>arXiv:0706.1355. [cited by applicant]
Krishan, Awtar, 1975, Rapid flow cytofluorometric analysis of mammalian cell cycle by propidium iodide staining. The Journal of Cell Biology vol. 66, pp. 188-193. [cited by applicant]
Eaves, J.D. et al. 2005. Hydrogen bonds in liquid water are broken only fleetingly. PNAS vol. 102(37): pp. 13019-13022. [cited by applicant]
Boughbina-Portoles, Aaron et al. 2021. Study. of the stability of citrate capped AgNPs in several environmental water matrices . . . Nanomaterials vol. 11, pp. 1-16. [cited by applicant]
NanoNutrients Avian LLC 2007-2009 Study and Field Trial Summaries, Lehi, Utah www.nanoavian.com 16 pages. [cited by applicant]
Shu, Li et al., 2013 Directly observe sodium chloride aggregates waltzing through dilute solutions pp. 213-223, Online Source: http://hdl.handle.net/10536/DRO/DU:30055194. [cited by applicant]
Mike Cary May 14, 2013 Quote to Gary Teague Farms in Fort Morgan, CO for OSML to optimize 5000 gallons of Gary Teague Farm's 32-0-0 $32/acre commercial proposal offer. 1 page. [cited by applicant]
Mike Cary Oct. 30, 2012 Memo—State by State Dept. Agriculture Registration Process re Commercial Fertilizer—Varys from State to State. Humic Fertilizer. 1 page. [cited by applicant]